奥地利、德国和瑞士SPECT与PET心肌灌注显像2024年第二次联合调查结果
该调查于2024年向奥地利、德国和瑞士开展核医学操作的机构发放问卷,分析SPECT与PET心肌灌注显像(MPI)的应用现状。结果显示三国MPI检查量呈稳定或增长趋势,指南依从性高,瑞士因广泛使用PET-MPI及在相机设备和衰减校正方面领先而表现突出。
要点
- 三国MPI检查量稳定或增长,门诊心脏科医生为主要转诊来源(46-71%)。
- 负荷试验以药物负荷为主(57-96%),门控SPECT和灌注评分应用频繁。
- 瑞士PET-MPI广泛使用,且在相机设备和衰减校正方面领先于奥地利和德国。
核心结论
- 第二次联合调查确认三国MPI显像呈积极趋势但存在差异,结果记录高水平的指南依从性。
- 瑞士因广泛使用PET-MPI而情况特殊,并在相机设备和衰减校正方面领先,其次是奥地利和德国。
研究设计与样本
- 2024年向奥地利、德国和瑞士开展核医学操作的机构发放问卷的第二次联合调查。
- 分析12个奥地利(10,689例SPECT)、198个德国(128,707例SPECT)和16个瑞士科室(11,593例MPI(2,911例SPECT;8,682例PET))的数据。
- 奥地利和德国PET MPI数量可忽略未纳入考虑。
主要发现
- 与2021年调查相比,奥地利50%、德国69%、瑞士69%的机构报告检查数量稳定或增加。
- 门诊心脏科医生是主要转诊组(46-71%),大多数负荷试验为药物负荷(57-96%)。
- SPECT协议:瑞士以一日法为主(77%),奥地利(41%)和德国(49%)使用两日法。
- 主要相机系统:奥地利(75%)和瑞士(100%)使用混合SPECT-CT,德国(56%)使用无CT的SPECT相机。
- 衰减校正常规执行率:瑞士100%、奥地利74%、德国35%;门控SPECT(82-99%)和灌注评分(82-88%)应用频繁。
关键数值与推荐
- 与2021年调查相比检查数量稳定或增加的机构比例:奥地利50%、德国69%、瑞士69%。
- 门诊心脏科医生转诊比例:46-71%;药物负荷试验比例:57-96%。
- SPECT一日法比例:瑞士77%;两日法比例:奥地利41%、德国49%。
- 混合SPECT-CT使用率:奥地利75%、瑞士100%;无CT的SPECT相机使用率:德国56%。
- 衰减校正常规执行率:瑞士100%、奥地利74%、德国35%;门控SPECT应用率82-99%,灌注评分应用率82-88%。
临床怎么用
- 调查结果可用于参考三国在MPI协议、相机设备和衰减校正方面的差异以优化本地实践。
- 高指南依从性提示应继续推广门控SPECT和灌注评分等规范操作。
- 瑞士PET-MPI的广泛使用及领先的设备与衰减校正配置可作为其他地区发展的参照。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: We herein present the results of the second survey on SPECT and PET myocardial perfusion imaging (MPI) in Austria, Germany, and Switzerland in 2024. METHODS: A questionnaire was sent to facilities practicing nuclear medicine. RESULTS: Data from 12 Austrian (10,689 SPECT), 198 German (128,707 SPECT), and 16 Swiss departments (11,593 MPI (2,911 SPECT; 8,682 PET)) were analysed. In Austria and Germany, the PET MPI numbers were negligible and not considered. In Austria 50%, in Germany 69%, and in Switzerland 69% of the facilities reported stable or increasing numbers of examinations compared to the 2021 survey. Ambulatory care cardiologists represented the major referral group (46-71%). Most stress tests were performed pharmacologically (57-96%). In SPECT imaging, the one-day protocol was predominant in Switzerland (77%), while the two-day protocol was used in Austria (41%) and Germany (49%). The primary camera systems used were hybrid SPECT-CT systems in Austria (75%) and Switzerland (100%), and SPECT cameras (without CT) in Germany (56%). Attenuation correction was regularly performed in Switzerland (100%), followed by Austria (74%), and Germany (35%). Both gated SPECT and perfusion scoring were frequently applied (gated SPECT 82-99%; perfusion scoring 82-88%). CONCLUSIONS: This second joint survey for 2024 confirms positive trends in MPI imaging in all three countries, albeit with differences. The results document a high level of guideline conformity. The situation in Switzerland is exceptional due to the widespread use of PET-MPI. Switzerland also leads in terms of camera equipment and attenuation correction followed by Austria and Germany.
引用
- Lindner O, Bucerius J, Derlin T, et al. SPECT and PET myocardial perfusion imaging in Austria, Germany, and Switzerland results of the 2nd joint survey 2024. Eur J Nucl Med Mol Imaging. 2026. PMID: 41718811. doi:10.1007/s00259-026-07790-w
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。